Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Geptanolimab (CBT-501), a humanized IgG4κ monoclonal antibody targeting PD-1 (Programmed Death-1), functions by competitively inhibiting the interaction between PD-L1/L2 and PD-1, thereby possessing potential use in cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Geptanolimab (CBT-501), a humanized IgG4κ monoclonal antibody targeting PD-1 (Programmed Death-1), functions by competitively inhibiting the interaction between PD-L1/L2 and PD-1, thereby possessing potential use in cancer research [1]. |
Molecular Weight | N/A |
CAS No. | 2348469-43-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Geptanolimab 2348469-43-0 inhibitor inhibit